$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Dec 11, 2025)
$1.12B
Market Cap
-
P/E Ratio
-1.31
EPS
$30.35
52 Week High
$2.82
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Nanobiotix SA is a pioneering clinical-stage biotechnology company based in Paris, France, specializing in the development of groundbreaking cancer therapies utilizing its proprietary nanotechnology platform. Committed to improving treatment efficacy and minimizing side effects, the company is advancing a robust pipeline of localized therapies across multiple clinical trial stages. With its innovative approach and strategic partnerships, Nanobiotix is poised to redefine oncology treatment paradigms and enhance patient outcomes on a global scale, positioning itself as a significant player in the fight against cancer.
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
WBD
NFLX
K
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
MTSR
BTBT
SNAP
IREN
NCLH
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
SMCI
KO
WULF
LUV
UBER
SMR
CNQ
SOUN
CLSK
LPTX
NVDA
WOK
VSME
PETS
PLUG
ORCL
ASST
KIND
IVP
IRBT
INTC
F
KVUE
TSLA
ADAP
DNN
AAL
AVGO
HOOD
MARA
WBD
NFLX
K
GOOGL
SOFI
RR
VALE
NIO
T
RGTI
BYND
PLTR
BAC
PFE
HL
ASBP
PLTD
GRAB
BITF
HPE
RKLB
QBTS
RIG
JBLU
AMD
CIFR
AG
CDE
MTSR
BTBT
SNAP
IREN
NCLH
FI
GOOG
NOK
MSFT
HBAN
CCL
PCG
SMCI
KO
WULF
LUV
UBER
SMR
CNQ
SOUN
CLSK